Optimal timing of non-pharmaceutical interventions during an epidemic

被引:7
|
作者
Huberts, Nick F. D. [1 ]
Thijssen, Jacco J. J. [1 ,2 ]
机构
[1] Univ York, Management Sch, York YO10 5ZF, England
[2] Univ York, Dept Math, York YO10 5ZF, England
关键词
Decision analysis; Continuous -time Markov chains; SIRD model; COVID-19; Optimal stopping; PUBLIC-HEALTH INTERVENTIONS; REAL OPTIONS; OPTIMAL OPERATION; INVESTMENT; VALUATION; DECISIONS; PLANTS; MODEL;
D O I
10.1016/j.ejor.2022.06.034
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
In response to the recent outbreak of the SARS-CoV-2 virus governments have aimed to reduce the virus's spread through, inter alia, non-pharmaceutical intervention. We address the question when such mea-sures should be implemented and, once implemented, when to remove them.These issues are viewed through a real-options lens and we develop an SIRD-like continuous-time Markov chain model to analyze a sequence of options: the option to intervene and introduce measures and, after intervention has started, the option to remove these. Measures can be imposed multiple times.We implement our model using estimates from empirical studies and, under fairly general assumptions, our main conclusions are that: (1) measures should be put in place not long after the first infections occur; (2) if the epidemic is discovered when there are many infected individuals already, then it is optimal never to introduce measures; (3) once the decision to introduce measures has been taken, these should stay in place until the number of susceptible or infected members of the population is close to zero; (4) it is never optimal to introduce a tier system to phase-in measures but it is optimal to use a tier system to phase-out measures; (5) a more infectious variant may reduce the duration of measures being in place; (6) the risk of infections being brought in by travelers should be curbed even when no other measures are in place. These results are robust to several variations of our base-case model.(c) 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:1366 / 1389
页数:24
相关论文
共 50 条
  • [21] Combining government, non-pharmaceutical interventions and vaccination in optimal control COVID-19
    Bohloli, Hamid
    Jamshidi, Hamid Reza
    Ebraze, Ali
    Khah, Fahimeh Rabbani
    INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT, 2023, 16 (01) : 61 - 69
  • [22] Challenges and Approaches of Non-pharmaceutical Interventions for Airport Operations During Pandemic Situations
    Rohde, Ann-Kathrin
    Pupkes, Birte
    Ernits, Rafael Mortensen
    Keiser, Dennis
    Luetjen, Michael
    Freitag, Michael
    DYNAMICS IN LOGISTICS (LDIC 2022), 2022, : 52 - 64
  • [23] The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout
    Gozzi, Nicolo
    Bajardi, Paolo
    Perra, Nicola
    Kouyos, Roger Dimitri
    Pitzer, Virginia E.
    Kouyos, Roger Dimitri
    Pitzer, Virginia E.
    Kouyos, Roger Dimitri
    Pitzer, Virginia E.
    PLOS COMPUTATIONAL BIOLOGY, 2021, 17 (09)
  • [24] Social Disparities in Adopting Non-pharmaceutical Interventions During COVID-19
    Mamelund, Svenn-Erik
    Dimka, Jessica
    Bakkeli, Nan Zou
    JOURNAL OF DEVELOPING SOCIETIES, 2021, 37 (03) : 302 - 328
  • [25] Optimal non-pharmaceutical intervention policy for Covid-19 epidemic via neuroevolution algorithm
    Saeidpour, Arash
    Rohani, Pejman
    EVOLUTION MEDICINE AND PUBLIC HEALTH, 2022, 10 (01) : 59 - 70
  • [26] Long-term spatial and population-structured planning of non-pharmaceutical interventions to epidemic outbreaks
    Kaleta, Mariusz
    Kesik-Brodacka, Malgorzata
    Nowak, Karolina
    Olszewski, Robert
    Sliwinski, Tomasz
    Zoltowska, Izabela
    COMPUTERS & OPERATIONS RESEARCH, 2022, 146
  • [27] The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states
    Pozo-Martin, Francisco
    Weishaar, Heide
    Cristea, Florin
    Hanefeld, Johanna
    Bahr, Thurid
    Schaade, Lars
    El Bcheraoui, Charbel
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (06) : 629 - 640
  • [28] Pharmaceutical and non-pharmaceutical interventions for controlling the COVID-19 pandemic
    Molla, Jeta
    Farhang-Sardroodi, Suzan
    Moyles, Iain R.
    Heffernan, Jane M.
    ROYAL SOCIETY OPEN SCIENCE, 2023, 10 (12):
  • [29] Impact of pharmaceutical and non-pharmaceutical interventions on COVID-19 in Tunisia
    Abroug, Hela
    Bennasrallah, Cyrine
    Ben Fredj, Manel
    Kacem, Meriem
    Ben Belgacem, Manel
    Dhouib, Wafa
    Gara, Amel
    Maatouk, Amani
    Zemni, Imen
    Ben Hassine, Donia
    Gallas, Syrine
    Bouanene, Ines
    Belguith, Asma Sriha
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [30] The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states
    Francisco Pozo-Martin
    Heide Weishaar
    Florin Cristea
    Johanna Hanefeld
    Thurid Bahr
    Lars Schaade
    Charbel El Bcheraoui
    European Journal of Epidemiology, 2021, 36 : 629 - 640